Buy Cancer 🌟 🎯

Novartis agreed to acquire an experimental breast-cancer drug from Synnovation Therapeutics for up to $3 billion.

: Companies are specifically targeting "in vivo" CAR-T therapies (which modify cells inside the body) and Antibody-Drug Conjugates (ADCs), which act like "guided missiles" to kill tumors while sparing healthy tissue. buy cancer

Novartis to Buy Breast-Cancer Drug From Synnovation ... - WSJ buy cancer